(Q41148188)

27 September 2017

1 reference

title

Biotherapy for antibiotic-associated and other diarrhoeas (English)

1 reference

27 September 2017

0 references

Roffe C

1

1 reference

PubMed ID

8852544

27 September 2017

language of work or name

1 reference

1 January 1996

1 reference

27 September 2017

1 reference

27 September 2017

32

1 reference

27 September 2017

1

1 reference

27 September 2017

1-10

1 reference

Identification of Clostridium difficile as a cause of pseudomembranous colitis

27 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Clostridium difficile and the aetiology of pseudomembranous colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

1 reference

7 January 2021

Influence of radiotherapy on intestinal microflora in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

The influence of the normal flora on Clostridium difficile colonisation of the gut.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Role of volatile fatty acids in colonization resistance to Clostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Purification and Characterization of Two Bacteriocins from Streptococcus faecium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Antibiotic-associated diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Drug-resistant Salmonella from animals fed antimicrobials

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Enterotoxigenic Clostridium perfringens: a possible cause of antibiotic-associated diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

A severe outbreak of Escherichia coli O157:H7--associated hemorrhagic colitis in a nursing home

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Role of candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Clostridium difficile infection: responses, relapses and re-infections

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Clostridium difficile-associated diarrhea and colitis: pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Recurrences of Clostridium difficile diarrhea not caused by the original infecting organism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Relapse versus reinfection withClostridium difficile

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

A double-blind, controlled trial of bioflorin (Streptococcus faecium SF68) in adults with acute diarrhea due to Vibrio cholerae and enterotoxigenic Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Treatment of relapsing Clostridium difficile diarrhoea by administration of a non-toxigenic strain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Saccharomyces boulardii'. A Review of an Innovative Biotherapeutic Agent

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Disposition kinetics of Saccharomyces boulardii in man and rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Treatment of Clostridium difficile diarrhoea with brewer's yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Yoghurt with Bifidobacterium longum reduces erythromycin-induced gastrointestinal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Saccharomyces boulardii for Clostridium difficile-associated enteropathies in infants.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Prevention of further recurrences of Clostridium difficile colitis with Saccharomyces boulardii

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Prevention of travellers' diarrhoea by Lactobacillus GG.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

A double-blind comparison of two different treatments for acute enteritis in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

Controlled trial of orally administered lactobacilli in acute infantile diarrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2896%2980002-8

7 January 2021

10.1016/S0163-4453(96)80002-8

Identifiers

DOI

1 reference

27 September 2017

1 reference

PubMed ID

8852544